|
1.
|
P LibbyInflammation in
atherosclerosisNature420868874200210.1038/nature0132312490960
|
|
2.
|
GK HanssonA HermanssonThe immune system in
atherosclerosisNat Immunol12204212201110.1038/ni.200121321594
|
|
3.
|
E WestphalM HerzbergI NeumannL BeibeiC
PilowskiC LiK WerdanH LoppnowNeutrophils process interleukin-1beta
and interleukin-18 precursors in a caspase-1-like fashion -
processing is inhibited by human vascular smooth muscle cellsEur
Cytokine Netw171928200616613759
|
|
4.
|
H LoppnowK WerdanW BuerkeVascular cells
contribute to atherosclerosis by cytokine- and
innate-immunity-related inflammatory mechanismsInnate
Immun146387200810.1177/175342590809124618713724
|
|
5.
|
C GabayC LamacchiaG PalmerIL-1 pathways in
inflammation and human diseasesNat Rev6232241201020177398
|
|
6.
|
M SahooI Ceballos-OlveraL del BarrioF
ReRole of the inflammasome, IL-1β, and IL-18 in bacterial
infectionsScientificWorldJournal11203720502011
|
|
7.
|
MG NeteaA SimonF van de VeerdonkBJ
KullbergJW van der MeerLA JoostenIL-1beta processing in host
defense: beyond the inflammasomesPLoS
Pathog6e1000661201010.1371/journal.ppat.100066120195505
|
|
8.
|
JA GracieSE RobertsonIB
McInnesInterleukin-18J Leukoc
Biol73213224200310.1189/jlb.0602313
|
|
9.
|
K SchroderJ TschoppThe
inflammasomesCell140821832201010.1016/j.cell.2010.01.04020303873
|
|
10.
|
F BauernfeindA AblasserE BartokS KimJ
Schmid-BurgkT CavlarV HornungInflammasomes: current understanding
and open questionsCell Mol Life
Sci68765783201110.1007/s00018-010-0567-421072676
|
|
11.
|
F MartinonV PétrilliA MayorA TardivelJ
TschoppGout-associated uric acid crystals activate the NALP3
inflammasomeNature440237241200610.1038/nature0451616407889
|
|
12.
|
V PétrilliS PapinC DostertA MayorF
MartinonJ TschoppActivation of the NALP3 inflammasome is triggered
by low intracellular potassium concentrationCell Death
Diff1415831589200717599094
|
|
13.
|
F MartinonL AgostiniE MeylanJ
TschoppIdentification of bacterial muramyl dipeptide as activator
of the NALP3/cryopyrin inflammasomeCurr
Biol1419291934200410.1016/j.cub.2004.10.02715530394
|
|
14.
|
L AgostiniF MartinonK BurnsMF McDermottPN
HawkinsJ TschoppNALP3 forms an IL-1β-processing inflammasome with
increased activity in Muckle-Wells autoinflammatory
disorderImmunity203193252004
|
|
15.
|
M RazmaraSM SrinivasulaL WangJL PoyetBJ
GeddesPS DiStefanoJ BertinES AlnemriCARD-8 protein, a new CARD
family member that regulates caspase-1 activation and apoptosisJ
Biol Chem2771395213958200210.1074/jbc.M10781120011821383
|
|
16.
|
H ZhangW FuNDPP1 is a novel CARD domain
containing protein which can inhibit apoptosis and suppress
NF-kappaB activationInt J Oncol2010351040200211956601
|
|
17.
|
A FontalbaV Martinez-TaboadaO GutierrezC
PipaonN BenitoA BalsaR BlancoJL Fernandez-LunaDeficiency of the
NF-kappaB inhibitor caspase activating and recruitment domain 8 in
patients with rheumatoid arthritis is associated with disease
severityJ
Immunol17948674873200710.4049/jimmunol.179.7.486717878386
|
|
18.
|
DPB McGovernH ButlerT AhmadM PaolucciDA
van HeelK NegoroP HysiJ RagoussisSPL TravisLR CardonDP JewellTUCAN
(CARD8) genetic variants and inflammatory bowel
diseaseGastroenterology13111901196200610.1053/j.gastro.2006.08.00817030188
|
|
19.
|
RD BagnallRG RobertsMM MirzaT TorigoeNJ
PrescottCG MathewNovel isoforms of the CARD8 (TUCAN) gene evade a
nonsense mutationEur J Hum
Genet16619625200810.1038/sj.ejhg.520199618212821
|
|
20.
|
M YamamotoT TorigoeK KamiguchiY HirohashiK
NakanishiC NabetaH AsanumaT TsuramaT SatoF HataA novel isoform of
TUCAN is overexpressed in human cancer tissues and suppresses both
caspase-8- and caspase-9-mediated apoptosisCancer
Res6587068714200510.1158/0008-5472.CAN-04-464916204039
|
|
21.
|
D WågsäterK JattaP OcayaJ DimbergA
SirsjöExpression of IL-1beta, IL-1 receptor type I and IL-1
receptor antagonist in human aortic smooth muscle cells: effects of
all-trans-retinoic acidJ Vasc Res43377382200616804330
|
|
22.
|
PS OlofssonY SheikineK JattaM GhaderiA
SamnegårdP ErikssonA SirsjöA functional interleukin-1 receptor
antagonist polymorphism influences atherosclerosis development. The
interleukin-1beta:interleukin-1 receptor antagonist balance in
atherosclerosisCirc J7315311536200910.1253/circj.CJ-08-1150
|
|
23.
|
J GaleaJ ArmstrongP GadsdonH HoldenSE
FrancisCM HoltInterleukin-1 beta in coronary arteries of patients
with ischemic heart diseaseAtheroscler Thromb Vasc
Biol1610001006199610.1161/01.ATV.16.8.10008696938
|
|
24.
|
WP ArendG PalmerC GabayIL-1, IL-18, and
IL-33 families of cytokinesImmunol
Rev2232038200810.1111/j.1600-065X.2008.00624.x18613828
|
|
25.
|
SF FisherMM MirzaCM OnnieD SoarsCM LewisNJ
PrescottCG MathewJ SandersonA ForbesC TodhunterCombined evidence
from three large british association studies rejects TUCAN/CARD8 as
an IBD susceptibility
geneGastroenterology13220782080200710.1053/j.gastro.2007.03.08617484911
|
|
26.
|
P LibbyJM OrdovasKR AugerAH RobbinsLK
BirinyiCA DinarelloEndotoxin and tumor necrosis factor induce
inter-leukin-1 gene expression in adult human vascular endothelial
cellsAm J Pathol12417918519863526909
|
|
27.
|
P ZhuL DuanJ ChenA XiongQ XuH ZhangF
ZhengZ TanF GongM FangGene silencing of NALP3 protects against
liver ischemia-reperfusion injury in miceHum Gene
Ther22853864201110.1089/hum.2010.14521128730
|
|
28.
|
K YamasakiJ MutoKR TaylorAL CogenD AudishJ
BertinEP GrantAJ CoyleA MisaghiHM HoffmanRL GalloNLRP3/cryopyrin is
necessary for interleukin-1beta (IL-1beta) release in response to
hyaluronan, an endogenous trigger of inflammation in response to
injuryJ Biol
Chem2841276212771200910.1074/jbc.M80608420019258328
|
|
29.
|
P KankkunenL TeirilaJ RintahakaH AleniusH
WolffS Matikainen(1,3)-beta-glucans activate both dectin-1 and
NLRP3 inflammasome in human macrophagesJ
Immunol18463356342201010.4049/jimmunol.090301920421639
|
